Instrument No.26 of 2002
Amendment of Statement of Principles
concerning
NON-ANEURYSMAL AORTIC ATHEROSCLEROTIC DISEASE
ICD-9-CM CODES: 440.0, 444.0, 444.1
Veterans’ Entitlements Act 1986
1. The Repatriation Medical Authority amends, under subsection 196B(2) of the Veterans’ Entitlements Act 1986, Instrument No.68 of 1998 by:
- in paragraph 8 deleting the definition of “diabetes mellitus”.
2. The amendment made by this instrument applies to all matters to which Instrument No.68 of 1998 and section 120A of the Act apply.
Dated this Ninth day of January 2002
The Common Seal of the )
Repatriation Medical Authority )
was affixed to this instrument )
in the presence of )
KEN DONALD
CHAIRMAN
Overview
The Veterans' Entitlements Act 1986, enacted to provide a framework for the provision of health care, income support, and other benefits to veterans and their families, was amended to address the issue of non-aneurysmal aortic atherosclerotic disease through the Veterans' Entitlements (Non-Aneurysmal Aortic Atherosclerotic Disease) Instrument 2002. This legislative instrument, numbered 26 of 2002, was developed by the Repatriation Medical Authority under subsection 196B(2) of the Act. It aims to refine and clarify the criteria for the recognition of certain medical conditions related to veterans' health. Specifically, this instrument removes the definition of "diabetes mellitus" from paragraph 8 of Instrument No.68 of 1998, ensuring that the legislative framework remains precise and focused on the conditions it was intended to cover. The amendment applies to all relevant matters governed by Instrument No.68 of 1998 and section 120A of the Act.
Scope and Application
The legislative instrument amends the Statement of Principles concerning Non-Aneurysmal Aortic Atherosclerotic Disease under the Veterans’ Entitlements Act 1986. This amendment, made by the Repatriation Medical Authority, specifically removes the definition of “diabetes mellitus” from Instrument No.68 of 1998. This change affects all matters to which Instrument No.68 of 1998 and section 120A of the Act apply, thereby impacting the criteria and principles used in assessing claims related to non-aneurysmal aortic atherosclerotic disease. The amendment is designed to refine the medical criteria used in the assessment of veterans' entitlements, ensuring that the legal framework remains relevant and accurate in its application. The geographic and jurisdictional reach of this amendment is limited to the Commonwealth, applying specifically to veterans who may be entitled to benefits under the Act. The amendment does not specify any exclusions or exemptions but rather modifies the existing legal framework to enhance the accuracy and relevance of the medical criteria used in assessing veterans' claims.
Key Provisions
The main operative sections of this legislative instrument concern the amendment of the Statement of Principles regarding non-aneurysmal aortic atherosclerotic disease, specifically under the Veterans’ Entitlements Act 1986. This instrument modifies Instrument No. 68 of 1998 by deleting the definition of “diabetes mellitus” in paragraph 8. This change is intended to refine the criteria for considering non-aneurysmal aortic atherosclerotic disease in veterans’ claims (s.1). The amendment applies to all matters governed by Instrument No. 68 of 1998 and section 120A of the Act, ensuring consistency and uniformity in the application of the new provisions (s.2).
The obligations and requirements imposed by this legislation are primarily administrative and definitional. The Repatriation Medical Authority is tasked with ensuring that the amendment is implemented across all relevant matters. This includes updating internal guidelines, training staff, and revising any documentation or forms that reference the previous definition of “diabetes mellitus.” The authority must also ensure that all stakeholders, including veterans and their representatives, are informed of the changes. The purpose of these obligations is to streamline the process of assessing claims related to non-aneurysmal aortic atherosclerotic disease, making it more accurate and efficient.
In terms of consequences for non-compliance, the legislative instrument does not explicitly state any offences or penalties. However, failure to adhere to the updated definitions and requirements could potentially lead to procedural errors in the assessment of claims. Such errors might result in delays, incorrect decisions, or additional administrative burdens. While there are no specified criminal or civil penalties in the instrument itself, any systemic issues arising from non-compliance could lead to broader scrutiny or corrective actions by oversight bodies. It is crucial for the Repatriation Medical Authority to ensure that the amendment is fully implemented to avoid any such repercussions.